SIC
MPLT

SJS Investment Consulting’s MapLight Therapeutics MPLT Stock Holding History

SJS Investment Consulting’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646 Buy
+18
New +$518 ﹤0.01% 2182

Other funds holding MPLT

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
MSWMA
Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SJS Investment Consulting's MPLT Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 18 shares worth $646. The stake represents ﹤0.01% of the portfolio and ranks #2182 among its holdings.

12 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • SJS Investment Consulting held 18 shares of MapLight Therapeutics worth $646 as of Q2 2026.
  • MapLight Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2182 holding.
  • 12 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.